Repare Therapeutics Appoints Steve Forte as CFO and Samarth Kulkarni to its Board of Directors

Cambridge, MA & Montreal, QC – Repare Therapeutics, a precision oncology company pioneering synthetic lethality to develop novel therapeutics that target specific vulnerabilities of tumors in genetically defined patient populations, announced today that it has made two additions to its leadership team and Board of Directors. Steve Forte, is appointed as Executive Vice President &…

Repare Therapeutics Raises US$68 Million Series A

Repare Therapeutics Raises US$68 Million Series A Novel cancer company founded by Versant Ventures   June 22, 2017, Montreal, Quebec and Cambridge, Mass.   Repare Therapeutics Inc. today announced a US$68 million Series A financing to advance its platform and pipeline of novel medicines that target genetically defined weaknesses of cancers. Founding investor Versant Ventures…